|
09:00 to
04:00
Course by Tim Albert. “How to get your paper written and published”.
|
|
04:30
to 07:00
True to Live Surgery. Session moderated by Giampaolo Gini
|
|
|
|
07:30
|
|
Welcome
Reception at the Conventum |
|
|
|
Sunday, June 19th
|
|
Macula
Pot Pourri
|
|
08:15
|
|
Opening
|
|
08:30
|
|
An unusual large tractional
macular break. Salim
Ben Yahia
|
|
08:36
|
|
One port PPV for ERM treatment:slit lamp & new AC maintainer in phakic patients. Cesare Forlini
|
|
08:43
|
|
Treatment of macular detachment
in patients with optic pit. Sven
Crafoord
|
|
08:53
|
|
Vitrectomy for optic pit-related
retinal detachment. Ferenc
Kuhn
|
|
09:03
|
|
Temporal RON for optic disc
pit associated with macular detachment. Murat
Karacorlu
|
|
09:10
|
|
Industry Announcement BAUSCH
& LOMB
|
|
09:15
|
|
Hemorrhagic macular
cysts in Terson syndrome. Ferenc Kuhn
|
|
09:23
|
|
Macular bleeding associated
with sexual activity in patient receiving anticoagulants. Salim BenYahia
|
|
09:31
|
|
Therapeutic effect of propranolol
on central serous chorioretinopathy. Ali Reza Ramezani
|
|
09:37
|
|
Results of PDT for idiopathic
polypoidal choroidal vasculopathy. S.
Natarajan
|
|
09:45
|
|
OCT in active choroidal
neovascularization secondary to pathologic
myopia. Murat Karacorlu
|
|
09:52
|
|
Discussion moderated by Khaled El Rakhawy
|
|
ARMD Medical
Treatment
|
|
10:45
|
|
The RPE in health and disease:
a role for lipofuscin and melanin in ARMD. Mike Boulton
|
|
11:00
|
|
Neoangiogenesis in
ARMD. Lennart Berglin
|
|
11:15
|
|
Is vitreous adhesion a risk
factor for CNV in AMD? Martine
Mauget-Faÿsse
|
|
11:23
|
|
Preferential Hyper acuity Perimeter:
clinical and angiographic correlations. Guy
L’Helgoual’ch
|
|
11:31
|
|
Variations of the visual function
according to the therapy. Christian
Malbrel
|
|
11:37
|
|
One year results of PDT in
eyes with choroidal neovascular membranes
due to ARMD. Tugrul
Altan
|
|
11:43
|
|
Industry Announcement ALCON
|
|
11:48
|
|
Encouraging results of PDT
with verteporfin in a clinical patient material of ARMD.
Christina Frennesson
|
|
11:58
|
|
PDT in the treatment of retinal
angiomatous proliferation. Marcio Nehemy
|
|
12:06
|
|
PDT for CNV in juvenile disciform
macular degeneration. Case report of 4 Icelandic cases. Ingimundur Gislason
|
|
12:15
|
|
Industry Announcement NOVARTIS
|
|
12:20
|
|
Discussion moderated by Christina Frennesson.
Related posters (Melanie Chak
and Claudia Kuhli)
|
|
|
|
|
|
02:00
|
|
Photodynamic therapy with visudyne:
complications. Guy L ‘Helgoual’ch
|
|
02:10
|
|
Histological characteristics
of neovascular membranes in AMD after PDT:
Comparison with spontaneous evolution, laser photocoagulation,radiotherapy. Didier
Ducournau
|
|
02:18
|
|
Combined treatment: PDT with
visudyne and IVT. Guy L’Helgoual’ch
|
|
02:28
|
|
Industry Announcement
CARL
ZEISS MEDITEC
|
|
02:33
|
|
Unicentric, randomized, open, parallel study
of comparison of PDT V/s IVT S. Natarajan
|
|
02:43
|
|
OCT evaluation of serous PED
after IVT and PDT for exudative ARMD.
Murat Karacorlu
|
|
02:53
|
|
Industry Announcement
ALCON
|
|
02:58
|
|
Anecortave acetate depot suspension for treatment
of exudative ARMD. Marc de Smet
|
|
03:06
|
|
Industry Announcement NOVARTIS
|
|
03:12
|
|
Rheopheresis to eradicate the drusen - CNV cascade. Frank
Koch
|
|
03:20
|
|
VEGF inhibition study in ocular
neovascularization: Outcomes from the phase II/III Macugen pivitol trials.Thomas Friberg
|
|
03:28
|
|
Discussion
moderated by Martine Mauget-Faÿsse. Related posters (Timothy W. Olsen)
|
|
04:30 to
06:00
Young EVRS Club
|
|
04:30
to 05:30
Country Delegate Assembly
|
|
04:30
to 05:30
Rosengren Club & Nordic VitreoRetinal Meeting
|
|
|
|
Medieval Thrills at Orebro Castle |
|
Monday, June
20th
|
|
ARMD Surgical
Approach
|
|
08:30
|
|
Surgical extraction of choroidal
neovascular membranes. Ziya Kapran
|
|
08:36
|
|
Current management
of juxtapapilar choroidal
neovascular lesions. Jaume Catala
|
|
08:44
|
|
Combined surgical ablation
and IVT for retinal angiomatous proliferation.
Francesco Boscia
|
|
08:50
|
|
Limited invasive procedures
to treat CNV’s in ARMD. Frank
Koch
|
|
08:58
|
|
Discussion moderated by Klaus Lucke
|
|
09:20
|
|
The use of tPA
in the management of sub-retinal haemorrhages. Theodoros Potamitis
|
|
09:28
|
|
Management of sub macular haemorrhage.
Pietro Rossi
|
|
09:36
|
|
Therapeutic approach to acute
submacular haemorrhage. Ziya Kapran
|
|
09:42
|
|
Vitrectomy and subretinal
tPA in submacular
haemorrhage. Mehmet Cakir
|
|
09:47
|
|
Role of subretinal
R-TPA in management of subretinal haemorrhage
due to ARMD. S. Natarajan
|
|
09:55
|
|
Discussion moderated by Karl Ulrich Bartz-Schmidt.
Related posters (Faruk Eroglu)
|
|
|
|
10:45
|
|
An Update on macular rotation
surgery for large subretinal neovascular
membranes. Klaus Lucke
|
|
11:00
|
|
Four years experience with
macular translocation. Zoran Tomic
|
|
11:06
|
|
New approaches to severe incyclotorsion
induced by macular translocation. Jonathan M. Holmes
|
|
11:14
|
|
Macular translocation in selected
cases of CNV and heavy silicone tamponade.
Cesare Forlini
|
|
11:20
|
|
Surgery for ARMD complicated
by massive subretinal haemorrhage. Nataliya Nehus
|
|
11:28
|
|
Full macular translocation
for massive submacular haemorrhage secondary to exudative
ARMD. Hassan Mortada
|
|
11:36
|
|
Full macular translocation
vs. PDT for Neovascular ARMD – Intermediate results of a prospective,
controlled, randomized pilot study. Karl Ulrich Bartz-Schmidt
|
|
11:46
|
|
Discussion
by Frank Koch.
|
|
12:10
|
|
Relya Zivojnovic
Award. Peep Algvere Lecture: “The challenge
of retinal transplantation.”
|
|
12:40
|
|
RPE and choroid
translocation. Jan Van Meurs
|
|
12:55
|
|
Artificial bruch’s
membrane implant: preliminary results
on animal. Fabio Patelli
|
|
01:01
|
|
Discussion moderated by Sven Crafoord. Related posters (Isabel
Pinilla).
|
|
|
|
|
|
Maculopathies: Pathogenesis,
Functional Testing & Imaging
|
|
02:30
|
|
Pathogenesis of macular edema
in branch retinal vein occlusion. New approach.
Jiri Rehak
|
|
02:38
|
|
Clinicodiagnostic correlation of macular disease. Jerzy Nawrocki
|
|
02:46
|
|
OCT as a screening method for
diabetic macular edema. Maria Sydorova
|
|
02:52
|
|
The value of OCT in AMD.
Urban Eriksson
|
|
03:02
|
|
Serous macular detachment in
diabetic cystoid macular edema. Murat Karacorlu
|
|
03:08
|
|
Macular function after scleral
buckling surgery for recent-onset RD. Patrik Schatz
|
|
03:16
|
|
Pre-and postoperative functional
and anatomical changes in patients with idiopathic ERM. Frank
Becquet
|
|
03:24
|
|
Evaluation of macular activity
using mfERG in patients with BRVO, before and after sheatotomy. Adam
Cywinski
|
|
03:30
|
|
ILM peeling in macular surgery:
a common physiopathological mechanism suggested by functional results.
Jean-François Le Rouic
|
|
03:38
|
|
ILM removal, how does it work?
Didier Ducournau
|
|
03:55
|
|
Discussion moderated by Ferenc Kuhn.
|
|
04:45
|
|
EVRS
General Assembly |
|
|
|
Swedish
Midsummer Nights' celebration |
|
Tuesday, June
21st
|
|
Vitreomacular Interface Visualization
and Surgical Approach
|
|
08:30
|
|
Visualization aids in VR interface
disorders, what does the staining pattern tell us? Silvia
Bopp
|
|
08:40
|
|
PPV with ILM peeling in MH
surgery. Yaprak Banu Unver
|
|
08:45
|
|
Trypan blue assisted removal of ILM and
ERM. Murat
Oncel
|
|
08:53
|
|
Vitreoretinal surgery for
ERM. Nur Acar
|
|
09:00
|
|
The use of Trypan
blue for the staining of the ILM. Why
not? Vincenzo Ferrara
|
|
09:08
|
|
Trypan blue staining for MH and macular
pucker surgery. Jerzy Nawrocki
|
|
09:16
|
|
Industry Announcement ALCON
|
|
09:21
|
|
ILM Peeling with ICG or trypan
blue in MH surgery: a prospective randomized trial. Hans
Hoerauf
|
|
09:31
|
|
RPE protection from ICG staining.
Cesare Forlini
|
|
09:38
|
|
Kenalog assisted removal of ILM in MH surgery. Theodoros Potamitis
|
|
09:42
|
|
Patterns of posterior cortical
vitreous attachment in myopic macular hole RD. Hassan
Mortada
|
|
09:52
|
|
Triam-time: “Parmesan” central vitrectomy
in macular disease. Cesare Forlini
|
|
10:00
|
|
Discussion moderated by Claudio Azzolini
|
|
|
|
|
|
10:50
|
|
Illuminated vitrector, facilitates bimanual
vitrectomy, and benefits in MH surgery without demand for face down.
|
